CD2AP Polyclonal Antibody

CD2AP Polyclonal Antibody

The CD2AP polyclonal antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CD2-associated protein (CD2AP) in various biological samples. This antibody is produced using advanced techniques of polyclonal antibody generation, purification, and characterization, ensuring its high quality and reliability for research and diagnostic applications.

The CD2AP polyclonal antibody is composed of a mixture of antibodies that recognize different epitopes of the CD2AP protein, providing a broad coverage of its antigenic determinants. This antibody has been extensively validated for its specificity and sensitivity using various techniques, including Western blotting, immunoprecipitation, and immunohistochemistry.

The CD2AP protein is a key component of the podocyte slit diaphragm, a specialized structure in the kidney that regulates the filtration of blood. Dysregulation of CD2AP expression or function has been implicated in various kidney diseases, including focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy. Therefore, the CD2AP polyclonal antibody is a valuable tool for studying the role of CD2AP in kidney function and disease, as well as for developing diagnostic and therapeutic strategies for these conditions.

In summary, the CD2AP polyclonal antibody is a high-quality and reliable immunological reagent that enables the detection and quantification of CD2AP in various biological samples. Its specificity and sensitivity make it an ideal tool for research and diagnostic applications in the field of kidney biology and disease.